Karanjin

Karanjin

SCHEMBL7164819

COc1c(-c2ccccc2)oc2c(ccc3occc32)c1=O.COc1c(-c2ccccc2)oc2c(ccc3occc32)c1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 1.00
▸ ALDH1A1 P00352 5/20 1.00
▸ CYP1A1 P04798 4/20 1.00
▸ CYP1B1 Q16678 4/20 1.00
▸ CYP3A4 P08684 4/20 1.00
▸ HPGD P15428 4/20 1.00
▸ HSD17B10 Q99714 4/20 1.00
▸ MAPT P10636 4/20 1.00
▸ CYP2D6 P10635 2/20 1.00
▸ CYP2C9 P11712 2/20 1.00
▸ TSHR P16473 2/20 1.00
▸ CYP2C19 P33261 2/20 1.00
▸ MAPK1 P28482 1/20 1.00
▸ CYP1A2 P05177 3/20 0.71
▸ ABCG2 Q9UNQ0 9/20 0.67
▸ ABCC1 P33527 3/20 0.67
▸ MEN1 O00255 2/20 0.56
▸ KMT2A Q03164 2/20 0.56
▸ THRB P10828 1/20 0.56
▸ TDP1 Q9NUW8 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Karanjin SCHEMBL247164 1.00 KDM4E (1.00) KDM4EALDH1A1CYP1A1CYP1B1CYP3A4
Karanjonol SCHEMBL21828762 0.80 KDM4E (0.71) KDM4EALDH1A1CYP1A1CYP1B1CYP3A4
Pongapin SCHEMBL17554011 0.79 CYP1A1 (1.00) KDM4EALDH1A1CYP1A1CYP1B1CYP3A4
SCHEMBL29598759 0.77 ABCG2 (0.64) KDM4EALDH1A1CYP1A1CYP1B1CYP3A4
SCHEMBL8511950 0.76 APP (0.74) KDM4EALDH1A1CYP1A1CYP1B1CYP3A4
SCHEMBL31238064 0.76 CYP1A1 (0.75) KDM4EALDH1A1CYP1A1CYP1B1CYP3A4
SCHEMBL29993383 0.76 ABCG2 (1.00) KDM4EALDH1A1CYP1A1CYP1B1CYP3A4
SCHEMBL253523 0.76 ABCG2 (1.00) KDM4EALDH1A1CYP1A1CYP1B1CYP3A4
SCHEMBL4282126 0.76 ABCG2 (0.69) KDM4EALDH1A1CYP1A1CYP1B1CYP3A4
SCHEMBL7374619 0.76 ABCG2 (0.69) KDM4EALDH1A1CYP1A1CYP1B1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6555523-B1 Such as 3',4'-diacetoxy-5,6,7-trimethoxyflavone or naringin in the treatment HIV, picornavirus, and/or respiratory virus CASCADE ESTATES LTD. (MU) 2003-04-29 — — US disclosed
EP-1223928-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS Prendergast, Patrick Thomas (IE) 2002-07-24 — — EP disclosed
WO-2001003681-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS PRENDERGAST PATRICK T (IE) 2001-01-18 — — WO disclosed
Send feedback